Pharmacological and Transcriptomic Exploration of β2-Adrenergic Receptor-Gα15 Signaling in THP-1-Derived Macrophages

Insights

This study reveals that beta-2 adrenergic receptor (β2AR) activation in macrophages signals differently through Gα15 and Gαs pathways. Understanding this dual signaling is key for developing new heart failure therapies.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Immunology

Background:

  • Myocardial infarction and heart failure are major causes of death globally.
  • Chronic beta-adrenergic receptor (βAR) activation can worsen heart failure, but β2AR may offer protection through alternative pathways.
  • Macrophages are crucial for cardiac repair, and β2AR signaling in these cells may involve Gα15.

Purpose of the Study:

  • To investigate the signaling bias between Gαs and Gα15 downstream of β2AR.
  • To determine the roles of Gαs and Gα15 in macrophage polarization and function.
  • To explore how β2AR agonists modulate macrophage polarization via distinct signaling pathways.

Main Methods:

  • Utilized TRUPATH triple assays to assess β2AR agonist potency for Gαs and Gα15.
  • Performed transcriptomic profiling of THP-1-derived macrophage-like cells treated with a β2AR agonist.
  • Employed knockdown strategies for Gαs and Gα15 to analyze their specific contributions.

Main Results:

  • Several β2AR agonists showed significantly higher potency for activating Gα15 compared to Gαs.
  • β2AR activation in macrophages promoted an M1-like transcriptional profile.
  • Gα15 knockdown was linked to M2 enrichment, while Gαs knockdown showed M1 enrichment; both pathways influenced repair hallmarks.

Conclusions:

  • β2AR ligands exhibit distinct pharmacological profiles toward Gαs and Gα15.
  • β2AR agonism modulates macrophage polarization through dual Gαs and Gα15 transducer signaling.
  • Gα15 signaling represents a noncanonical pathway influencing β2AR-induced transcriptional responses in macrophages, potentially impacting cardiac repair.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...